Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Short term Debt (2022 - 2024)

Roivant Sciences' Short term Debt history spans 3 years, with the latest figure at $12.0 million for Q2 2024.

  • For Q2 2024, Short term Debt fell 72.98% year-over-year to $12.0 million; the TTM value through Jun 2024 reached $12.0 million, down 72.98%, while the annual FY2024 figure was $12.0 million, 70.53% down from the prior year.
  • Short term Debt reached $12.0 million in Q2 2024 per ROIV's latest filing, roughly flat from $12.0 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $49.0 million in Q3 2023 to a low of $12.0 million in Q1 2024.
  • Average Short term Debt over 3 years is $34.5 million, with a median of $37.7 million recorded in 2022.
  • Peak YoY movement for Short term Debt: soared 37.04% in 2023, then tumbled 72.98% in 2024.
  • A 3-year view of Short term Debt shows it stood at $37.7 million in 2022, then increased by 21.16% to $45.7 million in 2023, then crashed by 73.75% to $12.0 million in 2024.
  • Per Business Quant, the three most recent readings for ROIV's Short term Debt are $12.0 million (Q2 2024), $12.0 million (Q1 2024), and $45.7 million (Q4 2023).